Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosisPer Soelberg Sørensen, Massimo Filippi, Steen Lisby et al.|Neurology|2014Cited by 276
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trialDavid H. Miller, Xavier Montalbán, Joseph P. Horrigan et al.|The Lancet Neurology|2012Cited by 77